8-10
Jul
2026
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
G37
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
4K52

Harbin Jixianglong Biotech Co., Ltd.

About Harbin Jixianglong Biotech Co., Ltd.

Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of peptides pharmaceuticals. Main Products: Eptifibatide, Somatostatin, Terlipressin Acetate, Thymalfasin, Atosiban Acetate, Carbetocin, Oxytocin, Ganirelix Acetate, Octreotide Acetate, Cetrorelix Acetate, Teriparatide, Bivalirudin, Liraglutide, Nesiritide, Abaloparatide, Semaglutide, Personalized cancer neoantigen peptide vaccine.

Meet us at

  • CPHI South East Asia 2026

    QSNCC, Bangkok, Thailand
    08 Jul 2026 - 10 Jul 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2022
Company types
Biopharmaceutical company
Contact info
  • North of Baoan Road, East of Changqing Stree, Harbin, China